{"id":55325,"date":"2023-03-29T18:07:29","date_gmt":"2023-03-29T16:07:29","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\/"},"modified":"2023-03-29T18:07:29","modified_gmt":"2023-03-29T16:07:29","slug":"vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\/","title":{"rendered":"Vim Chosen by Yuvo Health to Bring Next-Generation Technology to FQHCs"},"content":{"rendered":"
\n

\n\u2014 Vim will help empower Yuvo\u2019s healthcare partners by innovating value-based care delivery for their Medicare- and Medicaid-eligible populations \u2014\n<\/p>\n

NEW YORK–(BUSINESS WIRE)–Vim<\/a>, the leading point-of-care connection platform for U.S. healthcare, today announced an agreement with Yuvo Health<\/a> to make Vim\u2019s EHR-integrated, provider-enablement technology platform available to Yuvo Health\u2019s network of Federally Qualified Health Centers (FQHCs) and Community Health Centers.\n<\/p>\n

<\/a><\/p>\n

\nVim will provide point-of-care enablement technology for Yuvo Health\u2019s existing FQHC partners in New York state, as well as new partners as it expands and enters new markets. In the initial deployment, Vim will provide its context-aware, read-write capable applications for quality score performance and suspected diagnosis review.\n<\/p>\n

\n\u201cSince launching Yuvo Health over two years ago, we have been laser-focused on transitioning FQHCs into value-based care in the least disruptive way so they can focus on what they do best: providing quality care to communities in need,\u201d said Cesar Herrera, CEO and co-founder of Yuvo Health. \u201cAs a risk-bearing entity, we know what it takes to succeed under a value-based care model. That is why we chose to partner with Vim and leverage their EHR-integrated, point-of-care solution to fit into the existing workflows of our FQHC partners and ease their transformation to VBC operations. Combining the right resources with the right technology makes their lives \u2014 and the lives of their patients \u2014 easier.\u201d\n<\/p>\n

\nTogether, Yuvo Health and Vim will help more FQHCs and Community Health Centers more easily transition to value-based care operations. The partnership aims to improve quality performance, risk adjustment accuracy, and overall value-based care success measures, such as patient experience across this critical care delivery network in the U.S.\n<\/p>\n

\n\u201cAs a steward of making value-based care models accessible across all clinical settings, it is a great honor to be the point-of-care connectivity and enablement technology partner to Yuvo Health,\u201d said Oron Afek, CEO of Vim. \u201cVim\u2019s technology is designed to scale and drive value across diverse EHRs and practice environments, including in FQHC and Community Health Centers. We\u2019re excited for the meaningful impact we can have as part of Yuvo\u2019s enablement technology stack and to play a small part in their critical mission to scale value-based care within FQHCs.\u201d\n<\/p>\n

\nRecently, Yuvo Health announced a partnership with Public Health Solutions<\/a> to better support community health centers and address their patients\u2019 social drivers of health, as well as PCDC<\/a> to provide FQHCs with access to support services through upside risk contracts. In the coming months, the healthcare pioneer will announce additional FQHC and other partners.\n<\/p>\n

\nAbout Yuvo Health<\/b>\n<\/p>\n

\nLaunched in January 2021, Yuvo Health was founded in New York City by a fully BIPOC team with the common goal of bringing fair, quality care to underserved communities. A team that shares first-hand experience of the impact quality health care can make, they strive to instill more compassionate care within healthcare systems. Yuvo Health provides an industry-leading product of administrative and managed-care contracting solutions to Federally Qualified Health Centers (FQHC). Yuvo Health aims to relieve administrative pressure from FQHCs to allow them to focus completely on providing quality care to communities in need. While continuing to serve the downstate New York market, Yuvo anticipates providing their services across New York, the Midwest and the Mid-Atlantic regions. For more information, please visit yuvohealth.com<\/a>.\n<\/p>\n

\nAbout Vim<\/b>\n<\/p>\n

\nFounded in 2015, Vim connects data to workflow at health care\u2019s \u201clast mile\u201d: within clinical operations at the point of patient care. Health plans and medical providers of every size \u2013 from independent practitioners to integrated delivery systems \u2013 use Vim software to connect data and care across the health system. Vim\u2019s mission is to power affordable, high-quality health care through seamless connectivity. For more information, please visit getvim.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nD\u2019Anna Siegle
\n
dannas@getvim.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

\u2014 Vim will help empower Yuvo\u2019s healthcare partners by innovating value-based care delivery for their Medicare- and Medicaid-eligible populations \u2014 NEW YORK–(BUSINESS WIRE)–Vim, the leading point-of-care connection platform for U.S. healthcare, today announced an agreement with Yuvo Health to make Vim\u2019s EHR-integrated, provider-enablement technology platform available to Yuvo Health\u2019s network of Federally Qualified Health Centers … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55325","6":"format-standard","7":"category-industry"},"yoast_head":"\nVim Chosen by Yuvo Health to Bring Next-Generation Technology to FQHCs - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vim Chosen by Yuvo Health to Bring Next-Generation Technology to FQHCs - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"\u2014 Vim will help empower Yuvo\u2019s healthcare partners by innovating value-based care delivery for their Medicare- and Medicaid-eligible populations \u2014 NEW YORK–(BUSINESS WIRE)–Vim, the leading point-of-care connection platform for U.S. healthcare, today announced an agreement with Yuvo Health to make Vim\u2019s EHR-integrated, provider-enablement technology platform available to Yuvo Health\u2019s network of Federally Qualified Health Centers ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-29T16:07:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230329005152\/en\/766466\/21\/Vim_logo_%282%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Vim Chosen by Yuvo Health to Bring Next-Generation Technology to FQHCs\",\"datePublished\":\"2023-03-29T16:07:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\\\/\"},\"wordCount\":639,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230329005152\\\/en\\\/766466\\\/21\\\/Vim_logo_%282%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\\\/\",\"name\":\"Vim Chosen by Yuvo Health to Bring Next-Generation Technology to FQHCs - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230329005152\\\/en\\\/766466\\\/21\\\/Vim_logo_%282%29.jpg\",\"datePublished\":\"2023-03-29T16:07:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230329005152\\\/en\\\/766466\\\/21\\\/Vim_logo_%282%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230329005152\\\/en\\\/766466\\\/21\\\/Vim_logo_%282%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vim Chosen by Yuvo Health to Bring Next-Generation Technology to FQHCs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vim Chosen by Yuvo Health to Bring Next-Generation Technology to FQHCs - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\/","og_locale":"en_US","og_type":"article","og_title":"Vim Chosen by Yuvo Health to Bring Next-Generation Technology to FQHCs - Pharma Trend","og_description":"\u2014 Vim will help empower Yuvo\u2019s healthcare partners by innovating value-based care delivery for their Medicare- and Medicaid-eligible populations \u2014 NEW YORK–(BUSINESS WIRE)–Vim, the leading point-of-care connection platform for U.S. healthcare, today announced an agreement with Yuvo Health to make Vim\u2019s EHR-integrated, provider-enablement technology platform available to Yuvo Health\u2019s network of Federally Qualified Health Centers ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-29T16:07:29+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230329005152\/en\/766466\/21\/Vim_logo_%282%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Vim Chosen by Yuvo Health to Bring Next-Generation Technology to FQHCs","datePublished":"2023-03-29T16:07:29+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\/"},"wordCount":639,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230329005152\/en\/766466\/21\/Vim_logo_%282%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\/","url":"https:\/\/pharma-trend.com\/en\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\/","name":"Vim Chosen by Yuvo Health to Bring Next-Generation Technology to FQHCs - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230329005152\/en\/766466\/21\/Vim_logo_%282%29.jpg","datePublished":"2023-03-29T16:07:29+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230329005152\/en\/766466\/21\/Vim_logo_%282%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230329005152\/en\/766466\/21\/Vim_logo_%282%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/vim-chosen-by-yuvo-health-to-bring-next-generation-technology-to-fqhcs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Vim Chosen by Yuvo Health to Bring Next-Generation Technology to FQHCs"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55325","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55325"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55325\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55325"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55325"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55325"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}